| 000 | 01813 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250514214726.0 | ||
| 264 | 0 | _c20050531 | |
| 008 | 200505s 0 0 eng d | ||
| 022 | _a0001-690X | ||
| 024 | 7 |
_a10.1111/j.1600-0447.2004.00486.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNaber, D | |
| 245 | 0 | 0 |
_aRandomized double blind comparison of olanzapine vs. clozapine on subjective well-being and clinical outcome in patients with schizophrenia. _h[electronic resource] |
| 260 |
_bActa psychiatrica Scandinavica _cFeb 2005 |
||
| 300 |
_a106-15 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntipsychotic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aBenzodiazepines _xadministration & dosage |
| 650 | 0 | 4 | _aBrief Psychiatric Rating Scale |
| 650 | 0 | 4 |
_aClozapine _xadministration & dosage |
| 650 | 0 | 4 | _aDiagnostic and Statistical Manual of Mental Disorders |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aOlanzapine |
| 650 | 0 | 4 | _aQuality of Life |
| 650 | 0 | 4 |
_aSchizophrenia _xdiagnosis |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aRiedel, M | |
| 700 | 1 | _aKlimke, A | |
| 700 | 1 | _aVorbach, E-U | |
| 700 | 1 | _aLambert, M | |
| 700 | 1 | _aKühn, K-U | |
| 700 | 1 | _aBender, S | |
| 700 | 1 | _aBandelow, B | |
| 700 | 1 | _aLemmer, W | |
| 700 | 1 | _aMoritz, S | |
| 700 | 1 | _aDittmann, R W | |
| 773 | 0 |
_tActa psychiatrica Scandinavica _gvol. 111 _gno. 2 _gp. 106-15 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1600-0447.2004.00486.x _zAvailable from publisher's website |
| 999 |
_c15345982 _d15345982 |
||